Tissue	O
factor	O
transcription	O
driven	O
by	O
Egr-1	B-protein
is	O
a	O
critical	O
mechanism	O
of	O
murine	B-protein
pulmonary	I-protein
fibrin	I-protein
deposition	O
in	O
hypoxia	O
.	O

Local	O
hypoxemia	O
and	O
stasis	O
trigger	O
thrombosis	O
.	O

We	O
have	O
demonstrated	O
previously	O
that	O
in	O
a	O
murine	O
model	O
of	O
normobaric	O
hypoxia	O
pulmonary	O
fibrin	B-protein
deposition	O
is	O
a	O
result	O
of	O
expression	O
of	O
tissue	B-protein
factor	I-protein
,	O
especially	O
in	O
oxygen-deprived	B-protein
mononuclear	I-protein
phagocytes	I-protein
(	O
MPs	B-protein
)	O
.	O

We	O
now	O
show	O
that	O
transcription	B-protein
factor	I-protein
early-growth-response	I-protein
gene	I-protein
product	I-protein
(	O
Egr-1	B-protein
)	O
is	O
rapidly	O
activated	O
in	O
hypoxia	O
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
is	O
responsible	O
for	O
transcription	O
and	O
expression	O
of	O
tissue	B-protein
factor	I-protein
in	O
hypoxic	O
lung	O
.	O

MPs	B-protein
and	O
HeLa	B-cell_line
cells	I-cell_line
subjected	O
to	O
hypoxia	O
(	O
pO2	O
approximately	O
13	O
torr	O
)	O
had	O
increased	O
levels	O
of	O
tissue	B-RNA
factor	I-RNA
transcripts	I-RNA
(	O
approximately	O
18-fold	O
)	O
and	O
an	O
increased	O
rate	O
of	O
transcription	O
(	O
approximately	O
15-fold	O
)	O
,	O
based	O
on	O
nuclear	O
run-on	O
analysis	O
.	O

Gel-shift	O
analysis	O
of	O
nuclear	O
extracts	O
from	O
hypoxic	B-protein
MPs	I-protein
and	O
HeLa	B-cell_line
cells	I-cell_line
demonstrated	O
increased	O
DNA-binding	O
activity	O
at	O
the	O
serum	B-DNA
response	I-DNA
region	I-DNA
(	O
SRR	O
;	O
-111/+14	O
bp	O
)	O
of	O
the	O
tissue	B-DNA
factor	I-DNA
promoter	I-DNA
at	O
Egr-1	B-DNA
motifs	I-DNA
.	O

Using	O
32P-labeled	O
Egr	O
consensus	O
oligonucleotide	O
,	O
we	O
observed	O
induction	O
of	O
DNA-binding	O
activity	O
in	O
nuclear	O
extracts	O
from	O
hypoxic	O
lung	O
and	O
HeLa	B-cell_line
cells	I-cell_line
because	O
of	O
activation	O
of	O
Egr-1	B-protein
,	O
by	O
means	O
of	O
supershift	O
analysis	O
.	O

Transient	O
transfection	O
of	O
HeLa	B-cell_line
cells	I-cell_line
with	O
chimeric	B-DNA
plasmids	I-DNA
containing	O
wild-type	B-protein
or	I-protein
mutant	I-protein
SRR	I-protein
from	O
the	O
tissue	B-DNA
factor	I-DNA
promoter	I-DNA
showed	O
that	O
intact	B-DNA
Sp1	I-DNA
sites	I-DNA
are	O
necessary	O
for	O
basal	O
promoter	O
activity	O
,	O
whereas	O
the	O
integrity	O
of	O
Egr-1	B-DNA
sites	I-DNA
was	O
required	O
for	O
hypoxia-enhanced	O
expression	O
.	O

A	O
central	O
role	O
for	O
Egr-1	B-protein
in	O
hypoxia-mediated	O
tissue	O
factor	O
expression	O
was	O
confirmed	O
by	O
experiments	O
with	O
homozygous	O
Egr-1	B-protein
null	O
mice	O
;	O
wild-type	O
mice	O
subjected	O
to	O
oxygen	B-protein
deprivation	I-protein
expressed	I-protein
tissue	I-protein
factor	I-protein
and	O
showed	O
fibrin	B-protein
deposition	O
,	O
but	O
hypoxic	O
homozygous	O
Egr-1	B-protein
null	O
mice	O
displayed	O
neither	O
tissue	B-protein
factor	I-protein
nor	O
fibrin	B-protein
.	O

These	O
data	O
delineate	O
a	O
novel	O
biology	O
for	O
hypoxia-induced	O
fibrin	B-protein
deposition	O
,	O
in	O
which	O
oxygen	O
deprivation-induced	O
activation	O
of	O
Egr-1	B-protein
,	O
resulting	O
in	O
expression	O
of	O
tissue	B-protein
factor	I-protein
,	O
has	O
an	O
unexpected	O
and	O
central	O
role	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

95	NULL
,	NULL
pp	NULL
.	NULL

8298-8303	NULL
,	NULL
July	NULL
1998	NULL
Medical	NULL
Sciences	NULL
Tissue	NULL
factor	NULL
transcription	NULL
driven	NULL
by	NULL
Egr-1	NULL
is	NULL
a	NULL
critical	NULL
mechanism	NULL
of	NULL
murine	NULL
pulmonary	NULL
fibrin	NULL
deposition	NULL
in	NULL
hypoxia	NULL
(	NULL
thrombosis	NULL
/monocyte/transcription	NULL
)	NULL
SHr-Fancg	NULL
Yan*T	NULL
,	NULL
YU	NULL
SHan	NULL
ZoU*	NULL
,	NULL
Yun	NULL
Gao*	NULL
,	NULL
CHao	NULL
ZHAI*	NULL
,	NULL
NIGEL	NULL
MaACcKMaANF	NULL
,	NULL
STEPHEN	NULL
L.	NULL
Lee§	NULL
,	NULL
JEFFREY	NULL
MILBRANDTS§	NULL
,	NULL
Davi	NULL
PINsKY*	NULL
,	NULL
WALTER	NULL
KistELY	NULL
,	NULL
anp	NULL
Davin	NULL
StERN®*	NULL
*Departments	NULL
of	NULL
Physiology	NULL
and	NULL
Cellular	NULL
Biophysics	NULL
,	NULL
Surgery	NULL
,	NULL
and	NULL
Medicine	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
;	NULL
Departments	NULL
of	NULL
Pathology	NULL
and	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
New	NULL
Mexico	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Albuquerque	NULL
,	NULL
NM	NULL
87131	NULL
;	NULL
*Departments	NULL
of	NULL
Immunology	NULL
and	NULL
Vascular	NULL
Biology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
and	NULL
La	NULL
Jolla	NULL
Cancer	NULL
Research	NULL
Foundation	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
;	NULL
and	NULL
§Department	NULL
of	NULL
Pathology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
Communicated	NULL
by	NULL
Earl	NULL
W.	NULL
Davie	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
,	NULL
May	NULL
11	NULL
,	NULL
1998	NULL
(	NULL
received	NULL
for	NULL
review	NULL
February	NULL
5	NULL
,	NULL
1998	NULL
)	NULL
ABSTRACT	NULL
Local	NULL
hypoxemia	NULL
and	NULL
stasis	NULL
trigger	NULL
throm-bosis	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
previously	NULL
that	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
normobaric	NULL
hypoxia	NULL
pulmonary	NULL
fibrin	NULL
deposition	NULL
is	NULL
a	NULL
result	NULL
of	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
,	NULL
especially	NULL
in	NULL
oxygen-deprived	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
MPs	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
transcription	NULL
factor	NULL
early-growth-response	NULL
gene	NULL
product	NULL
(	NULL
Egr-1	NULL
)	NULL
is	NULL
rapidly	NULL
activated	NULL
in	NULL
hypoxia	NULL
,	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
is	NULL
responsible	NULL
for	NULL
transcription	NULL
and	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
in	NULL
hypoxic	NULL
lung	NULL
.	NULL

MPs	NULL
and	NULL
Hela	NULL
cells	NULL
subjected	NULL
to	NULL
hypoxia	NULL
(	NULL
pO	NULL
;	NULL
~13	NULL
torr	NULL
)	NULL
had	NULL
increased	NULL
levels	NULL
of	NULL
tissue	NULL
factor	NULL
transcripts	NULL
(	NULL
~18-fold	NULL
)	NULL
and	NULL
an	NULL
increased	NULL
rate	NULL
of	NULL
transcription	NULL
(	NULL
~15-fold	NULL
)	NULL
,	NULL
based	NULL
on	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic	NULL
MPs	NULL
and	NULL
HeLa	NULL
cells	NULL
demonstrated	NULL
increased	NULL
DNA-binding	NULL
activity	NULL
at	NULL
the	NULL
serum	NULL
response	NULL
region	NULL
(	NULL
SRR	NULL
;	NULL
-111/+14	NULL
bp	NULL
)	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
promoter	NULL
at	NULL
Egr-1	NULL
motifs	NULL
.	NULL

Using	NULL
P-labeled	NULL
Egr	NULL
consensus	NULL
oligonucleotide	NULL
,	NULL
we	NULL
observed	NULL
induction	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic	NULL
lung	NULL
and	NULL
HeLa	NULL
cells	NULL
because	NULL
of	NULL
activation	NULL
of	NULL
Egr-1	NULL
,	NULL
by	NULL
means	NULL
of	NULL
supershift	NULL
analysis	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
with	NULL
chimeric	NULL
plasmids	NULL
containing	NULL
wild-type	NULL
or	NULL
mutant	NULL
SRR	NULL
from	NULL
the	NULL
tissue	NULL
factor	NULL
promoter	NULL
showed	NULL
that	NULL
intact	NULL
Sp1	NULL
sites	NULL
are	NULL
necessary	NULL
for	NULL
basal	NULL
promoter	NULL
activity	NULL
,	NULL
whereas	NULL
the	NULL
integrity	NULL
of	NULL
Egr-1	NULL
sites	NULL
was	NULL
required	NULL
for	NULL
hypoxia-enhanced	NULL
expression	NULL
.	NULL

A	NULL
central	NULL
role	NULL
for	NULL
Egr-1	NULL
in	NULL
hypoxia-mediated	NULL
tissue	NULL
factor	NULL
expression	NULL
was	NULL
confirmed	NULL
by	NULL
experiments	NULL
with	NULL
homozygous	NULL
Egr-1	NULL
null	NULL
mice	NULL
;	NULL
wild-type	NULL
mice	NULL
subjected	NULL
to	NULL
oxygen	NULL
deprivation	NULL
expressed	NULL
tissue	NULL
factor	NULL
and	NULL
showed	NULL
fibrin	NULL
deposition	NULL
,	NULL
but	NULL
hypoxic	NULL
homozygous	NULL
Egr-1	NULL
null	NULL
mice	NULL
displayed	NULL
neither	NULL
tissue	NULL
factor	NULL
nor	NULL
fibrin	NULL
.	NULL

These	NULL
data	NULL
delineate	NULL
a	NULL
novel	NULL
biology	NULL
for	NULL
hypoxia-induced	NULL
fibrin	NULL
deposition	NULL
,	NULL
in	NULL
which	NULL
oxygen	NULL
deprivation-induced	NULL
activation	NULL
of	NULL
Egr-1	NULL
,	NULL
resulting	NULL
in	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
,	NULL
has	NULL
an	NULL
unexpected	NULL
and	NULL
central	NULL
role	NULL
.	NULL

Venous	NULL
thrombosis	NULL
,	NULL
long	NULL
associated	NULL
with	NULL
local	NULL
hypoxemia	NULL
and	NULL
stasis	NULL
,	NULL
has	NULL
a	NULL
substantial	NULL
morbidity	NULL
and	NULL
mortality	NULL
,	NULL
affecting	NULL
2-4	NULL
persons	NULL
per	NULL
1,000	NULL
each	NULL
year	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Many	NULL
studies	NULL
have	NULL
addressed	NULL
means	NULL
of	NULL
preventing	NULL
propagation	NULL
of	NULL
nascent	NULL
thrombi	NULL
,	NULL
by	NULL
inhibiting	NULL
the	NULL
contribution	NULL
of	NULL
platelets	NULL
and/or	NULL
plasma	NULL
coagulation	NULL
proteins	NULL
,	NULL
or	NULL
by	NULL
dissolving	NULL
preformed	NULL
fibrin	NULL
,	NULL
by	NULL
using	NULL
fibrinolytic	NULL
agents	NULL
.	NULL

Much	NULL
less	NULL
attention	NULL
has	NULL
focused	NULL
on	NULL
mechanisms	NULL
underlying	NULL
the	NULL
genesis	NULL
of	NULL
thrombi	NULL
,	NULL
such	NULL
as	NULL
that	NULL
which	NULL
occurs	NULL
in	NULL
stasis	NULL
,	NULL
accompanying	NULL
limb	NULL
immobilization	NULL
,	NULL
by	NULL
far	NULL
the	NULL
most	NULL
frequent	NULL
thrombotic	NULL
disorder	NULL
in	NULL
otherwise	NULL
healthy	NULL
individuals	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Almost	NULL
20	NULL
years	NULL
ago	NULL
,	NULL
brief	NULL
immobilization	NULL
of	NULL
canine	NULL
extremities	NULL
was	NULL
shown	NULL
to	NULL
depress	NULL
blood	NULL
oxygen	NULL
tension	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
National	NULL
Academy	NULL
of	NULL
Sciences	NULL
0027-8424/98/958298-6	NULL
$	NULL
2.00/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
http	NULL
:	NULL
//www.pnas.org	NULL
.	NULL

8298	NULL
in	NULL
the	NULL
deep	NULL
venous	NULL
circulation	NULL
to	NULL
virtually	NULL
undetectable	NULL
levels	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

A	NULL
particularly	NULL
susceptible	NULL
locus	NULL
for	NULL
thrombus	NULL
formation	NULL
in	NULL
this	NULL
condition	NULL
was	NULL
the	NULL
parietal	NULL
aspect	NULL
of	NULL
the	NULL
venous	NULL
valve	NULL
pocket	NULL
,	NULL
where	NULL
oxygen	NULL
tension	NULL
fell	NULL
off	NULL
most	NULL
quickly	NULL
,	NULL
strongly	NULL
suggesting	NULL
a	NULL
link	NULL
between	NULL
hypoxemia	NULL
and	NULL
activation	NULL
of	NULL
coagulation	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Although	NULL
multiple	NULL
metabolic	NULL
and	NULL
hemodynamic	NULL
factors	NULL
contribute	NULL
to	NULL
the	NULL
dysfunction	NULL
of	NULL
ischemic	NULL
vasculature	NULL
,	NULL
oxygen	NULL
deprivation	NULL
is	NULL
the	NULL
common	NULL
denominator	NULL
.	NULL

We	NULL
therefore	NULL
have	NULL
sought	NULL
to	NULL
analyze	NULL
how	NULL
it	NULL
contributes	NULL
to	NULL
triggering	NULL
of	NULL
procoagulant	NULL
events	NULL
in	NULL
hypoxemic	NULL
vasculature	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
found	NULL
that	NULL
in	NULL
a	NULL
hypoxic	NULL
environment	NULL
,	NULL
fibrin	NULL
deposition	NULL
occurred	NULL
in	NULL
pulmonary	NULL
vasculature	NULL
of	NULL
otherwise	NULL
normal	NULL
mice	NULL
,	NULL
and	NULL
that	NULL
this	NULL
was	NULL
a	NULL
result	NULL
of	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
,	NULL
especially	NULL
in	NULL
oxygen-deprived	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
6	NULL
)	NULL
.	NULL

We	NULL
now	NULL
have	NULL
observed	NULL
that	NULL
hypoxia	NULL
causes	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
gene	NULL
mediated	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
early-growth-response	NULL
gene	NULL
product	NULL
(	NULL
Egr-1	NULL
)	NULL
.	NULL

Hypoxic	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
MPs	NULL
)	NULL
and	NULL
HeLa	NULL
cells	NULL
showed	NULL
increased	NULL
tissue	NULL
factor	NULL
mRNA	NULL
and	NULL
increased	NULL
rates	NULL
of	NULL
transcrip-tion	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
normoxic	NULL
controls	NULL
.	NULL

Diminished	NULL
levels	NULL
of	NULL
oxygen	NULL
caused	NULL
enhanced	NULL
nuclear-binding	NULL
activity	NULL
for	NULL
Egr-1	NULL
sites	NULL
in	NULL
the	NULL
tissue	NULL
factor	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
consensus	NULL
Egr	NULL
oligonucleotide	NULL
.	NULL

Based	NULL
on	NULL
transient	NULL
transfection	NULL
analysis	NULL
,	NULL
Egr-1	NULL
motifs	NULL
in	NULL
the	NULL
tissue	NULL
factor	NULL
promoter	NULL
were	NULL
critical	NULL
for	NULL
hypoxia-mediated	NULL
transcription	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
gene	NULL
.	NULL

Experiments	NULL
in	NULL
homozygous	NULL
Egr-1	NULL
null	NULL
mice	NULL
displayed	NULL
parallel	NULL
suppression	NULL
of	NULL
tissue	NULL
factor	NULL
induction	NULL
and	NULL
fibrin	NULL
formation	NULL
,	NULL
compared	NULL
with	NULL
wild-type	NULL
controls	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
central	NULL
role	NULL
for	NULL
Egr-1	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
activation	NULL
of	NULL
Egr-1	NULL
is	NULL
responsible	NULL
for	NULL
tissue	NULL
factor	NULL
expression	NULL
in	NULL
hypoxemic	NULL
vasculature	NULL
,	NULL
thereby	NULL
triggering	NULL
a	NULL
procoagulant	NULL
pathway	NULL
eventuating	NULL
in	NULL
fibrin	NULL
formation	NULL
.	NULL

METHODS	NULL
Cell	NULL
Culture	NULL
and	NULL
in	NULL
Vifro	NULL
Analysis	NULL
of	NULL
Tissue	NULL
Factor	NULL
Gene	NULL
Expression	NULL
.	NULL

MPs	NULL
were	NULL
harvested	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
by	NULL
differential	NULL
centrifugation	NULL
(	NULL
Histopaque	NULL
1077	NULL
,	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
plated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
10	NULL
%	NULL
)	NULL
for	NULL
48	NULL
hr	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Experiments	NULL
were	NULL
also	NULL
performed	NULL
with	NULL
the	NULL
rat	NULL
macrophage	NULL
line	NULL
(	NULL
NR8383	NULL
)	NULL
obtained	NULL
from	NULL
ATCC	NULL
and	NULL
grown	NULL
in	NULL
F12K	NULL
medium	NULL
supplemented	NULL
with	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
15	NULL
%	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
,	NULL
obtained	NULL
from	NULL
ATCC	NULL
,	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
fetal	NULL
bovine	NULL
serum	NULL
Abbreviations	NULL
:	NULL
EGR-1	NULL
,	NULL
ecarly-growth-response	NULL
gene	NULL
product	NULL
;	NULL
MP	NULL
,	NULL
mononuclear	NULL
phagocyte	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
;	NULL
SRR	NULL
,	NULL
serum	NULL
response	NULL
region	NULL
;	NULL
HIF-1	NULL
,	NULL
hypoxia-inducible	NULL
factor-1	NULL
.	NULL

tTo	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Department	NULL
of	NULL
Physiology	NULL
and	NULL
Cellular	NULL
Biophysics	NULL
,	NULL
P	NULL
&	NULL
S	NULL
11-420	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
630	NULL
West	NULL
168th	NULL
Street	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032.	NULL
e-mail	NULL
:	NULL
sy18	NULL
@	NULL
columbia.edu	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
%	NULL
)	NULL
.	NULL

Serum-starved	NULL
cells	NULL
(	NULL
24	NULL
hr	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
hypoxia	NULL
after	NULL
replacement	NULL
of	NULL
the	NULL
growth	NULL
medium	NULL
with	NULL
fresh	NULL
medium	NULL
preequilibrated	NULL
with	NULL
the	NULL
hypoxic	NULL
gas	NULL
mixture	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
balance	NULL
of	NULL
the	NULL
atmosphere	NULL
was	NULL
made	NULL
up	NULL
of	NULL
carbon	NULL
dioxide	NULL
(	NULL
pCO	NULL
;	NULL
~	NULL
40	NULL
torr	NULL
)	NULL
and	NULL
water	NULL
vapor	NULL
(	NULL
~47	NULL
torr	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
were	NULL
kept	NULL
constant	NULL
,	NULL
via	NULL
an	NULL
automated	NULL
valve	NULL
system	NULL
.	NULL

Oxygen	NULL
content	NULL
of	NULL
medium	NULL
bathing	NULL
the	NULL
cells	NULL
was	NULL
maintained	NULL
between	NULL
12	NULL
and	NULL
14	NULL
torr	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
maintained	NULL
throughout	NULL
experiments	NULL
performed	NULL
under	NULL
the	NULL
above	NULL
hypoxic	NULL
conditions	NULL
up	NULL
to	NULL
the	NULL
longest	NULL
time	NULL
point	NULL
.	NULL

Northern	NULL
Analysis	NULL
.	NULL

Cultured	NULL
MPs	NULL
or	NULL
HeLa	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
serum	NULL
for	NULL
24	NULL
hr	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
normoxia	NULL
or	NULL
hypoxia	NULL
for	NULL
4	NULL
hr	NULL
followed	NULL
by	NULL
harvesting	NULL
of	NULL
RNA	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
30	NULL
ug/lane	NULL
)	NULL
,	NULL
isolated	NULL
by	NULL
using	NULL
TRIzol	NULL
Reagent	NULL
(	NULL
GIBCO/	NULL
BRL	NULL
)	NULL
from	NULL
MPs	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
or	NULL
murine	NULL
lung	NULL
,	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
0.8	NULL
%	NULL
agarose-formaldehyde	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
Duralon-UV	NULL
membranes	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
hybridized	NULL
with	NULL
human	NULL
or	NULL
mouse	NULL
tissue	NULL
factor	NULL
cDNA	NULL
fragments	NULL
(	NULL
6	NULL
)	NULL
,	NULL
the	NULL
latter	NULL
labeled	NULL
by	NULL
using	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
,	NULL
DuPont	NULL
)	NULL
,	NULL
and	NULL
then	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
Biomax	NULL
film	NULL
at	NULL
-80°C	NULL
.	NULL

Membranes	NULL
were	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
human	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

Nuclear	NULL
Run-On	NULL
Analysis	NULL
.	NULL

Cultured	NULL
MPs	NULL
or	NULL
HeLa	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
serum	NULL
for	NULL
24	NULL
hr	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
normoxia	NULL
or	NULL
hypoxia	NULL
for	NULL
4	NULL
hr	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
and	NULL
in	NULL
vitro	NULL
transcription	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Gel-Shift	NULL
Assays	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
MPs	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
or	NULL
murine	NULL
lung	NULL
after	NULL
exposure	NULL
to	NULL
hypoxia	NULL
by	NULL
the	NULL
procedure	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
oligonucleotide	NULL
probes	NULL
from	NULL
the	NULL
serum	NULL
response	NULL
region	NULL
(	NULL
SRR	NULL
)	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
gene	NULL
,	NULL
denoted	NULL
R1	NULL
(	NULL
-114/-89	NULL
)	NULL
,	NULL
R2	NULL
(	NULL
-96/-66	NULL
)	NULL
,	NULL
and	NULL
R3	NULL
(	NULL
-77/=-46	NULL
)	NULL
(	NULL
9	NULL
)	NULL
or	NULL
consensus	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
AP-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
HIF-1	NULL
[	NULL
5'-GCCCTACGTGCT-GTCTCA-3	NULL
``	NULL
;	NULL
(	NULL
10	NULL
)	NULL
]	NULL
,	NULL
Sp1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
nuclear	NULL
factor	NULL
interleukin	NULL
6	NULL
(	NULL
NF-IL-6	NULL
)	NULL
(	NULL
7	NULL
)	NULL
,	NULL
or	NULL
Egr	NULL
(	NULL
Santa	NULL
Cruz	NULL
Bio-technology	NULL
)	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
double-stranded	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
5	NULL
'	NULL
end-labeled	NULL
with	NULL
[	NULL
°°P	NULL
]	NULL
JATP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
)	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
standard	NULL
procedures	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
antiserum	NULL
to	NULL
Egr-1	NULL
or	NULL
nonimmune	NULL
IgG	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
hr	NULL
,	NULL
and	NULL
then	NULL
the	NULL
procedure	NULL
was	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Samples	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
lane	NULL
)	NULL
were	NULL
loaded	NULL
directly	NULL
onto	NULL
nondenaturing	NULL
polyacrylamide/bisacrylamide	NULL
(	NULL
6	NULL
%	NULL
)	NULL
gels	NULL
prepared	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
(	NULL
45	NULL
mM	NULL
Tris/45	NULL
mM	NULL
boric	NULL
acid/1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
pre-run	NULL
for	NULL
20	NULL
min	NULL
before	NULL
samples	NULL
were	NULL
loaded	NULL
.	NULL

Electrophoresis	NULL
was	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1.5-2	NULL
hr	NULL
at	NULL
200	NULL
V.	NULL
For	NULL
competition	NULL
studies	NULL
,	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
one	NULL
of	NULL
the	NULL
above	NULL
unlabeled	NULL
probes	NULL
was	NULL
employed	NULL
.	NULL

Transient	NULL
Transfection	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
using	NULL
lipofectamine	NULL
reagent	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

Supercoiled	NULL
plasmid	NULL
DNAs	NULL
were	NULL
prepared	NULL
by	NULL
Endofree	NULL
Plasmid	NULL
Maxikit	NULL
(	NULL
Qiagen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
pTF	NULL
(	NULL
-111/+14	NULL
)	NULL
Luc	NULL
,	NULL
pT-F	NULL
(	NULL
EGR-1m	NULL
)	NULL
Luc	NULL
,	NULL
pTF	NULL
(	NULL
SP1m	NULL
)	NULL
Luc	NULL
,	NULL
and	NULL
pTF	NULL
(	NULL
EGR-1m/SP1	NULL
m	NULL
)	NULL
-Luc	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
make	NULL
constructs	NULL
pYSF60	NULL
and	NULL
pYSF61	NULL
,	NULL
the	NULL
two	NULL
27-bp	NULL
oligonucleotides	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
were	NULL
ligated	NULL
to	NULL
the	NULL
basal	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
7	NULL
)	NULL
and	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
from	NULL
pGL3	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
day	NULL
before	NULL
transfection	NULL
,	NULL
exponentially	NULL
growing	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
trypsinization	NULL
,	NULL
re-plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
4	NULL
X	NULL
10°	NULL
per	NULL
35-mm	NULL
well	NULL
in	NULL
DMEM	NULL
containing	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
2	NULL
%	NULL
)	NULL
,	NULL
and	NULL
cultures	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
until	NULL
they	NULL
reached	NULL
50-80	NULL
%	NULL
confluence	NULL
.	NULL

DNA-lipofectamine	NULL
complexes	NULL
were	NULL
prepared	NULL
by	NULL
combining	NULL
one	NULL
of	NULL
the	NULL
above	NULL
constructs	NULL
(	NULL
1	NULL
mg	NULL
)	NULL
and	NULL
pCMV-B-galactosidase	NULL
DNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
12	NULL
ul	NULL
of	NULL
lipofectamine	NULL
reagent	NULL
in	NULL
0.2	NULL
ml	NULL
of	NULL
serum-free	NULL
OPTI-MEM1	NULL
Reduced	NULL
Serum	NULL
Medium	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
45	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
8299	NULL
min	NULL
.	NULL

Then	NULL
,	NULL
the	NULL
complexes	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
OPTI-MEM1	NULL
.	NULL

After	NULL
6	NULL
hr	NULL
of	NULL
transfection	NULL
,	NULL
cultures	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
balanced	NULL
salt	NULL
solution	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
then	NULL
the	NULL
medium	NULL
was	NULL
changed	NULL
to	NULL
DMEM	NULL
containing	NULL
2	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

After	NULL
another	NULL
30	NULL
hr	NULL
at	NULL
37°C	NULL
,	NULL
medium	NULL
from	NULL
cultures	NULL
was	NULL
aspirated	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
balanced	NULL
salt	NULL
solution	NULL
,	NULL
and	NULL
serum-free	NULL
DMEM	NULL
was	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
for	NULL
6	NULL
hr	NULL
at	NULL
37°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
normoxia	NULL
or	NULL
hypoxia	NULL
.	NULL

After	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
Reporter	NULL
Lysis	NULL
Buffer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
Lumat	NULL
LB9501	NULL
(	NULL
Wal-lac	NULL
,	NULL
Gaithersburg	NULL
MD	NULL
)	NULL
.	NULL

pCMV-B-galactosidase	NULL
(	NULL
CLON-TECH	NULL
)	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
efficiency	NULL
of	NULL
transfection	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
based	NULL
on	NULL
B-galactosidase	NULL
activity	NULL
in	NULL
the	NULL
same	NULL
well	NULL
;	NULL
this	NULL
is	NULL
termed	NULL
relative	NULL
luciferase	NULL
activity	NULL
(	NULL
x	NULL
axis	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
Vivo	NULL
Studies	NULL
of	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
and	NULL
Fibrin	NULL
Deposition	NULL
.	NULL

Homozygous	NULL
Egr-1	NULL
knockout	NULL
mice	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
or	NULL
nontransgenic	NULL
littermate	NULL
controls	NULL
were	NULL
exposed	NULL
to	NULL
hypoxia	NULL
by	NULL
using	NULL
an	NULL
environmental	NULL
chamber	NULL
designed	NULL
for	NULL
small	NULL
animals	NULL
(	NULL
5	NULL
)	NULL
.	NULL

After	NULL
the	NULL
indicated	NULL
time	NULL
in	NULL
hypoxia	NULL
,	NULL
tissue	NULL
was	NULL
fixed	NULL
in	NULL
formalin	NULL
and	NULL
processed	NULL
for	NULL
immunohistochemistry	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Immunoblotting	NULL
for	NULL
fibrin	NULL
epitopes	NULL
,	NULL
using	NULL
an	NULL
antibody	NULL
to	NULL
fibrin	NULL
y-y	NULL
chain	NULL
crosslinks	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
localization	NULL
tissue	NULL
factor	NULL
antigen	NULL
in	NULL
tissue	NULL
sections	NULL
,	NULL
by	NULL
immunohistochemical	NULL
techniques	NULL
(	NULL
6	NULL
)	NULL
,	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
.	NULL

Fibrin	NULL
immunostaining	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
the	NULL
same	NULL
method	NULL
and	NULL
antibody	NULL
prepared	NULL
to	NULL
fibrin	NULL
y-y	NULL
chain	NULL
crosslinks	NULL
.	NULL

RESULTS	NULL
Role	NULL
of	NULL
Egr-1	NULL
in	NULL
Hypoxia-Induced	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
in	NULL
Cultured	NULL
Mononuclear	NULL
Phagocytes	NULL
and	NULL
HeLa	NULL
Cells	NULL
.	NULL

Because	NULL
hypoxic	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
mRNA	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
a	NULL
cultured	NULL
mutant	NULL
hepatoma	NULL
cell	NULL
line	NULL
deficient	NULL
in	NULL
hypoxia-inducible	NULL
factor-1	NULL
(	NULL
16	NULL
)	NULL
,	NULL
implicating	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
HIF-1	NULL
(	NULL
17	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
pathway	NULL
was	NULL
likely	NULL
to	NULL
underlie	NULL
oxygen	NULL
deprivation-mediated	NULL
regulation	NULL
of	NULL
tissue	NULL
factor	NULL
expression	NULL
.	NULL

Tissue	NULL
factor	NULL
up-regulation	NULL
occurred	NULL
prominently	NULL
in	NULL
MPs	NULL
in	NULL
hypoxic	NULL
lung	NULL
,	NULL
and	NULL
human	NULL
peripheral	NULL
blood-derived	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
culture	NULL
also	NULL
showed	NULL
enhanced	NULL
tissue	NULL
factor	NULL
levels	NULL
on	NULL
exposure	NULL
to	NULL
hypoxia	NULL
.	NULL

Up-regulation	NULL
of	NULL
tissue	NULL
factor	NULL
mRNA	NULL
(	NULL
~18-fold	NULL
based	NULL
on	NULL
densitometry	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
hypoxic	NULL
MPs	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
as	NULL
a	NULL
result	NULL
of	NULL
,	NULL
in	NULL
large	NULL
part	NULL
,	NULL
de	NULL
novo	NULL
transcription	NULL
as	NULL
shown	NULL
by	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
;	NULL
~15-fold	NULL
increase	NULL
in	NULL
tissue	NULL
factor	NULL
transcripts	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
further	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
activation	NULL
,	NULL
a	NULL
cell	NULL
system	NULL
other	NULL
than	NULL
blood	NULL
monocytes	NULL
had	NULL
to	NULL
be	NULL
identified	NULL
,	NULL
because	NULL
human	NULL
monocytes	NULL
do	NULL
not	NULL
proliferate	NULL
and	NULL
established	NULL
monocyte	NULL
cell	NULL
lines	NULL
did	NULL
not	NULL
reproduc-ibly	NULL
show	NULL
hypoxia-mediated	NULL
up-regulation	NULL
of	NULL
tissue	NULL
factor	NULL
.	NULL

HeLa	NULL
cells	NULL
subjected	NULL
to	NULL
oxygen	NULL
deprivation	NULL
displayed	NULL
increased	NULL
tissue	NULL
factor	NULL
mRNA	NULL
,	NULL
maximal	NULL
within	NULL
4	NULL
hr	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
principally	NULL
reflecting	NULL
increased	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
;	NULL
~10-fold	NULL
increase	NULL
in	NULL
tissue	NULL
factor	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
highlighted	NULL
a	NULL
role	NULL
for	NULL
Egr-1	NULL
in	NULL
vascular	NULL
injury	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
contribution	NULL
of	NULL
a	NULL
trio	NULL
of	NULL
12	NULL
bp	NULL
overlapping	NULL
Egr-1	NULL
and	NULL
Spl	NULL
DNA-binding	NULL
sites	NULL
in	NULL
the	NULL
SRR	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
promoter	NULL
(	NULL
-111/+14	NULL
bp	NULL
)	NULL
in	NULL
regulation	NULL
of	NULL
tissue	NULL
factor	NULL
expression	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
spanning	NULL
each	NULL
of	NULL
the	NULL
Egr-1/Sp1	NULL
DNA-binding	NULL
sites	NULL
,	NULL
termed	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
(	NULL
9	NULL
)	NULL
,	NULL
were	NULL
*P	NULL
-labeled	NULL
and	NULL
employed	NULL
in	NULL
EMSA	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic/normoxic	NULL
HeLa	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

Rat	NULL
MP	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
with	NULL
HeLa	NULL
cells	NULL
are	NULL
not	NULL
shown	NULL
)	NULL
from	NULL
both	NULL
normoxic	NULL
and	NULL
hypoxic	NULL
cultures	NULL
showed	NULL
a	NULL
strong	NULL
constitutive	NULL
band	NULL
(	NULL
labeled	NULL
Sp1	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
;	NULL
results	NULL
with	NULL
the	NULL
R2	NULL
probe	NULL
are	NULL
shown	NULL
)	NULL
whose	NULL
appearance	NULL
was	NULL
blocked	NULL
by	NULL
inclusion	NULL
of	NULL
excess	NULL
unlabeled	NULL
Sp1	NULL
probe	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Egr	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Only	NULL
hypoxic	NULL
cultures	NULL
showed	NULL
a	NULL
new	NULL
gel-shift	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
3	NULL
;	NULL
this	NULL
hypoxia-inducible	NULL
band	NULL
is	NULL
labeled	NULL
Egr-1	NULL
)	NULL
whose	NULL
appearance	NULL
8300	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

A	NULL
1°	NULL
2	NULL
B	NULL
H	NULL
N	NULL
#	NULL
=	NULL
-r	NULL
comme	NULL
--	NULL
TF	NULL
..	NULL
--	NULL
f-actin	NULL
<	NULL
e	NULL
CWB	NULL
_	NULL
--	NULL
{	NULL
-actin	NULL
N	NULL
H	NULL
C	NULL
102	NULL
3	NULL
4	NULL
5060	NULL
7	NULL
48	NULL
9g	NULL
10	NULL
f	NULL
12	NULL
14	NULL
tt	NULL
w	NULL
an	NULL
#	NULL
B	NULL
-	NULL
#	NULL
#	NULL
®	NULL
a	NULL
#	NULL
-TF	NULL
-	NULL
>	NULL
N	NULL
HO	NULL
N	NULL
HOON	NULL
OH	NULL
ON	NULL
OH	NULL
N	NULL
OH	NULL
ON	NULL
H	NULL
FBS	NULL
PMA	NULL
L222	NULL
Ecg	NULL
okie	NULL
oy	NULL
LLJ	NULL
0.5	NULL
1	NULL
2	NULL
4	NULL
6	NULL
8	NULL
hrs	NULL
D	NULL
H	NULL
N	NULL
fond	NULL
-	NULL
*-	NULL
eum	NULL
-e-	NULL
TF	NULL
en	NULL
wee	NULL
--	NULL
f-actin	NULL
3	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
hypoxia	NULL
on	NULL
tissue	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

(	NULL
4	NULL
and	NULL
C	NULL
)	NULL
Northern	NULL
analysis	NULL
for	NULL
tissue	NULL
factor	NULL
transcripts	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
phagocytes	NULL
cells	NULL
,	NULL
4	NULL
)	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
~0.5	NULL
X	NULL
105	NULL
cells	NULL
,	NULL
C	NULL
)	NULL
in	NULL
serum-free	NULL
medium	NULL
were	NULL
subjected	NULL
to	NULL
normoxia	NULL
(	NULL
N	NULL
)	NULL
or	NULL
hypoxia	NULL
(	NULL
H	NULL
;	NULL
pO	NULL
»	NULL
~	NULL
12-14	NULL
torr	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
HeLa	NULL
)	NULL
or	NULL
for	NULL
4	NULL
hr	NULL
(	NULL
mononuclear	NULL
phagocytes	NULL
)	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
loading	NULL
30	NULL
ug/lane	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
using	NULL
*°P-labeled	NULL
cDNA	NULL
for	NULL
human	NULL
tissue	NULL
factor	NULL
(	NULL
Upper	NULL
)	NULL
or	NULL
human	NULL
B-actin	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

FBS	NULL
and	NULL
PMA	NULL
denote	NULL
cultures	NULL
exposed	NULL
to	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
20	NULL
%	NULL
)	NULL
or	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
50	NULL
ng/m1	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
each	NULL
case	NULL
.	NULL

(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
Nuclear	NULL
run-on	NULL
analysis	NULL
for	NULL
the	NULL
rate	NULL
of	NULL
tissue	NULL
factor	NULL
transcription	NULL
.	NULL

Mononuclear	NULL
phagocytes	NULL
(	NULL
~10	NULL
``	NULL
cells	NULL
,	NULL
B	NULL
)	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
~10°	NULL
cells	NULL
,	NULL
DD	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
normoxia	NULL
or	NULL
hypoxia	NULL
(	NULL
as	NULL
above	NULL
)	NULL
for	NULL
4	NULL
hr	NULL
,	NULL
nuclei	NULL
were	NULL
harvested	NULL
,	NULL
labeled	NULL
by	NULL
incubation	NULL
with	NULL
[	NULL
«	NULL
-*2P	NULL
]	NULL
dUTP	NULL
for	NULL
1	NULL
hr	NULL
,	NULL
the	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
radioactivity	NULL
was	NULL
hybridized	NULL
with	NULL
cDNA	NULL
probes	NULL
for	NULL
tissue	NULL
factor	NULL
or	NULL
-actin	NULL
,	NULL
the	NULL
latter	NULL
already	NULL
immobilized	NULL
on	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
minimum	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

was	NULL
blocked	NULL
by	NULL
excess	NULL
unlabeled	NULL
Egr	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Sp1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
greater	NULL
intensity	NULL
of	NULL
the	NULL
proximal	NULL
constitutive	NULL
Spl	NULL
bands	NULL
relative	NULL
to	NULL
the	NULL
inducible	NULL
Egr	NULL
band	NULL
,	NULL
it	NULL
was	NULL
difficult	NULL
to	NULL
accurately	NULL
judge	NULL
competition	NULL
with	NULL
unlabeled	NULL
Sp1	NULL
oligonucleotide	NULL
for	NULL
Egr	NULL
DNA-binding	NULL
activity	NULL
with	NULL
probes	NULL
containing	NULL
overlapping	NULL
Sp1	NULL
and	NULL
Egr	NULL
sites	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
experiments	NULL
also	NULL
were	NULL
performed	NULL
separately	NULL
by	NULL
using	NULL
consensus	NULL
Sp1	NULL
and	NULL
Egr	NULL
probes	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
demonstrated	NULL
specificity	NULL
of	NULL
the	NULL
observed	NULL
protein-DNA	NULL
binding	NULL
complexes	NULL
,	NULL
because	NULL
excess	NULL
unlabeled	NULL
oligonucleotide	NULL
probes	NULL
corresponding	NULL
to	NULL
consensus	NULL
sequences	NULL
for	NULL
AP-1	NULL
,	NULL
HIF-1	NULL
,	NULL
and	NULL
NF-IL-6	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
observed	NULL
gel-shift	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
nuclear	NULL
extracts	NULL
of	NULL
hypoxic	NULL
MPs	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
studied	NULL
with	NULL
*°P-labeled	NULL
R1	NULL
and	NULL
R3	NULL
probes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
these	NULL
comparable	NULL
observations	NULL
with	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
,	NULL
further	NULL
in	NULL
vitro	NULL
studies	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
more	NULL
conveniently	NULL
manipulated	NULL
HeLa	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
A	NULL
B	NULL
for	NULL
3	NULL
4	NULL
5060	NULL
7	NULL
8	NULL
9	NULL
ps	NULL
i*	NULL
$	NULL
#	NULL
me	NULL
do	NULL
dit	NULL
#	NULL
#	NULL
ma	NULL
--	NULL
Sp1	NULL
K	NULL
w	NULL
»	NULL
#	NULL
#	NULL
-	NULL
...	NULL
<	NULL
-	NULL
Egt	NULL
as	NULL
ho	NULL
te	NULL
me	NULL
``	NULL
po	NULL
.	NULL

§	NULL
y	NULL
150	NULL
15	NULL
m§§88ara	NULL
kgég	NULL
‘	NULL
ggT	NULL
?	NULL

$	NULL
f	NULL
b	NULL
f	NULL
f	NULL
f	NULL
£	NULL
l	NULL
}	NULL
f	NULL
G	NULL
23:5	NULL
:	NULL
Io	NULL
£	NULL
C	NULL
1020	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
405	NULL
wa	NULL
wat	NULL
-	NULL
tt	NULL
&	NULL
e	NULL
&	NULL
«	NULL
31.5323	NULL
ggﬁ	NULL
’	NULL
ﬁ	NULL
FP	NULL
N	NULL
Ho	NULL
N	NULL
H	NULL
3	NULL
5	NULL
£	NULL
£	NULL
=	NULL
+/+	NULL
-/-	NULL
_	NULL
Genotype	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

EMSA	NULL
of	NULL
tissue	NULL
factor	NULL
promoter	NULL
DNA-binding	NULL
motifs	NULL
:	NULL
effect	NULL
of	NULL
hypoxia	NULL
.	NULL

(	NULL
4	NULL
)	NULL
EMSA	NULL
using	NULL
R2	NULL
from	NULL
the	NULL
tissue	NULL
factor	NULL
promoter	NULL
.	NULL

Rat	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
~10	NULL
``	NULL
,	NULL
4	NULL
)	NULL
were	NULL
exposed	NULL
to	NULL
normoxia	NULL
(	NULL
N	NULL
)	NULL
or	NULL
hypoxia	NULL
(	NULL
H	NULL
;	NULL
pO	NULL
~	NULL
12-14	NULL
torr	NULL
)	NULL
for	NULL
45	NULL
min	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
*°P-labeled	NULL
oligonucleotide	NULL
for	NULL
R2	NULL
(	NULL
-96/-66	NULL
bp	NULL
;	NULL
ref	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Each	NULL
lane	NULL
received	NULL
10	NULL
ug/lane	NULL
of	NULL
total	NULL
nuclear	NULL
extract	NULL
protein	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
bands	NULL
corresponding	NULL
to	NULL
Egr	NULL
and	NULL
Sp1	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
unlabeled	NULL
lower	NULL
band	NULL
observed	NULL
in	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
may	NULL
represent	NULL
Sp3	NULL
(	NULL
38	NULL
)	NULL
.	NULL

A	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
unlabeled	NULL
(	NULL
cold	NULL
)	NULL
oligonucleotide	NULL
with	NULL
a	NULL
consensus	NULL
sequence	NULL
of	NULL
Spl	NULL
or	NULL
Egr	NULL
was	NULL
added	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
using	NULL
consensus	NULL
oligonucleotide	NULL
probe	NULL
Egr	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
harvested	NULL
from	NULL
normoxic/hypoxic	NULL
HeLa	NULL
cells	NULL
and	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
indicated	NULL
P-labeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Excess	NULL
unlabeled	NULL
Sp1	NULL
,	NULL
AP-1	NULL
,	NULL
or	NULL
Egr	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
certain	NULL
lanes	NULL
,	NULL
and	NULL
either	NULL
rabbit	NULL
anti-Egr-1	NULL
IgG	NULL
(	NULL
1:5	NULL
and	NULL
1:50	NULL
dilution	NULL
)	NULL
or	NULL
nonimmune	NULL
IgG	NULL
(	NULL
1:5	NULL
)	NULL
was	NULL
added	NULL
to	NULL
other	NULL
lanes	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
using	NULL
consensus	NULL
oligonucleotide	NULL
for	NULL
Egr	NULL
,	NULL
as	NULL
above	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
normoxic/hypoxic	NULL
murine	NULL
lung	NULL
.	NULL

Mice	NULL
were	NULL
subjected	NULL
to	NULL
hypoxia	NULL
(	NULL
~6	NULL
%	NULL
oxygen	NULL
;	NULL
ref	NULL
.	NULL

6	NULL
)	NULL
for	NULL
45	NULL
min	NULL
,	NULL
lungs	NULL
were	NULL
rapidly	NULL
harvested	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
above	NULL
,	NULL
and	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
anti-Egr-1	NULL
IgG	NULL
or	NULL
nonimmune	NULL
IgG	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
was	NULL
added	NULL
.	NULL

(	NULL
D	NULL
)	NULL
)	NULL
EMSA	NULL
using	NULL
consensus	NULL
oligonucleotide	NULL
for	NULL
Sp-1	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
normoxic/hypoxic	NULL
murine	NULL
lung	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
above	NULL
(	NULL
+/+	NULL
,	NULL
wild-type	NULL
mice	NULL
;	NULL
-/-	NULL
,	NULL
Egr-1	NULL
null	NULL
mice	NULL
)	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
minimum	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

To	NULL
facilitate	NULL
analysis	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
R2	NULL
probe	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
*	NULL
>	NULL
P-labeled	NULL
consensus	NULL
oligonucleotides	NULL
for	NULL
only	NULL
Spl	NULL
or	NULL
Egr	NULL
.	NULL

EMSA	NULL
using	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

consensus	NULL
Egr	NULL
probe	NULL
showed	NULL
a	NULL
gel-shift	NULL
band	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
not	NULL
from	NULL
normoxic	NULL
,	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
excess	NULL
unlabeled	NULL
Egr	NULL
probe	NULL
blocked	NULL
appearance	NULL
of	NULL
the	NULL
hypoxia-induced	NULL
gel-shift	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
Sp1	NULL
or	NULL
AP-1	NULL
were	NULL
without	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Inclusion	NULL
of	NULL
antibody	NULL
to	NULL
Egr-1	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
blocked	NULL
appearance	NULL
of	NULL
the	NULL
hypoxia-induced	NULL
gel-shift	NULL
band	NULL
observed	NULL
with	NULL
the	NULL
Egr	NULL
probe	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
amount	NULL
of	NULL
antibody	NULL
added	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
nonimmune	NULL
IgG	NULL
was	NULL
without	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
data	NULL
,	NULL
EMSA	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic	NULL
murine	NULL
lung	NULL
(	NULL
harvested	NULL
within	NULL
45	NULL
min	NULL
of	NULL
oxygen	NULL
deprivation	NULL
)	NULL
similarly	NULL
displayed	NULL
an	NULL
enhancement	NULL
of	NULL
DNA-binding	NULL
activity	NULL
for	NULL
the	NULL
Egr	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
latter	NULL
gel-shift	NULL
band	NULL
disappeared	NULL
on	NULL
addition	NULL
of	NULL
antibody	NULL
to	NULL
Egr-1	NULL
,	NULL
but	NULL
not	NULL
with	NULL
nonimmune	NULL
IgG	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Quite	NULL
different	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic	NULL
cells	NULL
and	NULL
lung	NULL
were	NULL
evaluated	NULL
for	NULL
DNA-binding	NULL
activity	NULL
for	NULL
the	NULL
Sp1	NULL
consensus	NULL
oligonucleotide	NULL
.	NULL

With	NULL
*°P-Sp1	NULL
probe	NULL
,	NULL
a	NULL
prominent	NULL
band	NULL
of	NULL
equal	NULL
intensity	NULL
was	NULL
observed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
normoxic	NULL
and	NULL
hypoxic	NULL
HeLa	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
hypoxic	NULL
wild-type	NULL
murine	NULL
lung	NULL
using	NULL
the	NULL
Sp-1	NULL
probe	NULL
showed	NULL
no	NULL
change	NULL
in	NULL
intensity	NULL
of	NULL
the	NULL
band	NULL
when	NULL
comparing	NULL
samples	NULL
from	NULL
hypoxic	NULL
and	NULL
normoxic	NULL
tissue	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
+/+	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
Sp-1	NULL
DNA-binding	NULL
activity	NULL
in	NULL
hypoxic	NULL
and	NULL
normoxic	NULL
lung	NULL
was	NULL
shown	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
-/-	NULL
)	NULL
.	NULL

To	NULL
better	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
Egr-1	NULL
in	NULL
driving	NULL
tissue	NULL
factor	NULL
transcription	NULL
in	NULL
HeLa	NULL
cells	NULL
subjected	NULL
to	NULL
hypoxia	NULL
,	NULL
transient	NULL
transfection	NULL
was	NULL
performed	NULL
with	NULL
chimeric	NULL
promoter-reporter	NULL
constructs	NULL
spanning	NULL
the	NULL
SRR	NULL
(	NULL
-111/+14	NULL
bp	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

As	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
efficiency	NULL
of	NULL
transfection	NULL
,	NULL
cotransfection	NULL
was	NULL
performed	NULL
with	NULL
pCMV-B-galactosidase	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
fold-increase	NULL
in	NULL
luciferase	NULL
activity	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
(	NULL
see	NULL
Methods	NULL
)	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
was	NULL
observed	NULL
in	NULL
hypoxic	NULL
cultures	NULL
after	NULL
transfection	NULL
with	NULL
wild-type	NULL
SRR	NULL
in	NULL
which	NULL
both	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
sites	NULL
were	NULL
intact	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
;	NULL
~6-fold	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
normoxic	NULL
controls	NULL
.	NULL

A	NULL
mutant	NULL
construct	NULL
in	NULL
which	NULL
all	NULL
three	NULL
Egr-1	NULL
sites	NULL
in	NULL
the	NULL
SRR	NULL
were	NULL
inactivated	NULL
showed	NULL
no	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
when	NULL
transfected	NULL
cultures	NULL
were	NULL
exposed	NULL
to	NULL
hypoxia	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
a	NULL
central	NULL
role	NULL
for	NULL
Sp1	NULL
in	NULL
basal	NULL
tissue	NULL
factor	NULL
expression	NULL
(	NULL
9	NULL
)	NULL
,	NULL
mutational	NULL
inactivation	NULL
of	NULL
all	NULL
three	NULL
Spl	NULL
sites	NULL
blocked	NULL
both	NULL
basal	NULL
and	NULL
hypoxia	NULL
enhanceable	NULL
expression	NULL
of	NULL
luciferase	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
construct	NULL
in	NULL
which	NULL
both	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
sites	NULL
were	NULL
inactivated	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
showed	NULL
expression	NULL
similar	NULL
to	NULL
that	NULL
with	NULL
the	NULL
construct	NULL
in	NULL
which	NULL
Sp1	NULL
was	NULL
inactivated	NULL
.	NULL

These	NULL
data	NULL
led	NULL
us	NULL
to	NULL
further	NULL
dissect	NULL
the	NULL
role	NULL
of	NULL
Egr-1	NULL
by	NULL
making	NULL
a	NULL
construct	NULL
composed	NULL
of	NULL
the	NULL
Egr	NULL
consensus	NULL
DNA-binding	NULL
motif	NULL
,	NULL
the	NULL
basal	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
-80/+18	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
.	NULL

Two	NULL
constructs	NULL
were	NULL
prepared	NULL
:	NULL
pYSF60	NULL
,	NULL
corresponding	NULL
to	NULL
wild-type	NULL
Egr	NULL
consensus	NULL
site	NULL
,	NULL
and	NULL
pYSF61	NULL
,	NULL
corresponding	NULL
to	NULL
a	NULL
mutationally	NULL
inactivated	NULL
Egr	NULL
consensus	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
these	NULL
constructs	NULL
into	NULL
HeLa	NULL
cells	NULL
demonstrated	NULL
hypoxic	NULL
enhancement	NULL
of	NULL
reporter	NULL
expression	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
intact	NULL
Egr	NULL
DNA-binding	NULL
site	NULL
,	NULL
but	NULL
not	NULL
with	NULL
the	NULL
mutationally	NULL
inactivated	NULL
Egr	NULL
construct	NULL
.	NULL

Role	NULL
of	NULL
Egr-1	NULL
in	NULL
Pulmonary	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
and	NULL
Fibrin	NULL
Deposition	NULL
in	NULL
a	NULL
Murine	NULL
Model	NULL
of	NULL
Hypoxia	NULL
/Hypoxemia	NULL
.	NULL

To	NULL
move	NULL
from	NULL
an	NULL
association	NULL
of	NULL
Egr-1	NULL
with	NULL
enhanced	NULL
tissue	NULL
factor	NULL
expression	NULL
in	NULL
hypoxia	NULL
to	NULL
a	NULL
cause-effect	NULL
relationship	NULL
,	NULL
we	NULL
studied	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Our	NULL
analysis	NULL
was	NULL
performed	NULL
in	NULL
Egr-1	NULL
null	NULL
mice	NULL
and	NULL
nontransgenic	NULL
controls	NULL
,	NULL
and	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

Exposure	NULL
of	NULL
female	NULL
Egr-1	NULL
knockout	NULL
mice	NULL
to	NULL
hypoxia	NULL
resulted	NULL
in	NULL
a	NULL
severely	NULL
blunted	NULL
increase	NULL
in	NULL
tissue	NULL
factor	NULL
mRNA	NULL
in	NULL
lung	NULL
:	NULL
compared	NULL
with	NULL
an	NULL
~20-fold	NULL
increase	NULL
in	NULL
tissue	NULL
factor	NULL
transcripts	NULL
in	NULL
wild-type	NULL
mice	NULL
subjected	NULL
to	NULL
hypoxia	NULL
(	NULL
versus	NULL
normoxic	NULL
controls	NULL
)	NULL
,	NULL
there	NULL
was	NULL
only	NULL
an	NULL
~2-fold	NULL
increase	NULL
in	NULL
tissue	NULL
factor	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
8301	NULL
A	NULL
~111	NULL
+14	NULL
pTF	NULL
(	NULL
-1	NULL
1	NULL
1/+14	NULL
)	NULL
Luc	NULL
fik	NULL
(	NULL
ik	NULL
»	NULL
Cae	NULL
f	NULL
pTF	NULL
(	NULL
EGR-1m	NULL
)	NULL
Luc	NULL
.	NULL

Em	NULL
»	NULL
pTF	NULL
(	NULL
$	NULL
P1m	NULL
)	NULL
Luc	NULL
HO	NULL
)	NULL
pTF	NULL
(	NULL
EGR-1m/	NULL
,	NULL
Cae	NULL
a	NULL
N	NULL
SPIm	NULL
)	NULL
Luc	NULL
0	NULL
20	NULL
4	NULL
60	NULL
8	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
B	NULL
pYSF60	NULL
TK	NULL
lue	NULL
-GGaTCCaGCoocaccoaccoacooccca-KCL_	NULL
]	NULL
pYSF61	NULL
-GGATCCAGCTAGGGGGAGCTAGGGCGA-RKL__	NULL
]	NULL
E	NULL
N	NULL
H	NULL
0	NULL
2	NULL
4	NULL
6	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Hypoxia-inducible	NULL
tissue	NULL
factor	NULL
expression	NULL
results	NULL
from	NULL
transcriptional	NULL
activation	NULL
at	NULL
Egr-1	NULL
sites	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Transient	NULL
cotransfection	NULL
of	NULL
HeLa	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
either	NULL
pTF	NULL
(	NULL
-111/+14	NULL
)	NULL
Luc	NULL
,	NULL
pTF	NULL
(	NULL
EGR-1	NULL
m	NULL
)	NULL
Luc	NULL
,	NULL
pTF	NULL
(	NULL
SP1	NULL
m	NULL
)	NULL
Luc	NULL
,	NULL
or	NULL
pTF	NULL
(	NULL
EGR-1	NULL
m/SP1	NULL
m	NULL
)	NULL
Luc	NULL
,	NULL
and	NULL
pCMV-	NULL
-galactosidase	NULL
.	NULL

Cultures	NULL
were	NULL
transfected	NULL
with	NULL
each	NULL
of	NULL
the	NULL
indicated	NULL
constructs	NULL
by	NULL
using	NULL
the	NULL
lipofectamine	NULL
procedure	NULL
(	NULL
GIBCO	NULL
)	NULL
,	NULL
and	NULL
then	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
normoxia	NULL
(	NULL
N	NULL
)	NULL
or	NULL
hypoxia	NULL
(	NULL
H	NULL
)	NULL
for	NULL
5	NULL
hr	NULL
.	NULL

Luciferase	NULL
and	NULL
-galactosidase	NULL
activity	NULL
were	NULL
then	NULL
determined	NULL
.	NULL

Relative	NULL
luciferase	NULL
activity	NULL
is	NULL
luciferase	NULL
activity	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transient	NULL
transfection	NULL
of	NULL
HeLa	NULL
cells	NULL
using	NULL
pYSF60	NULL
(	NULL
consensus	NULL
Egr	NULL
wild-type	NULL
sequence	NULL
)	NULL
or	NULL
pYSF61	NULL
(	NULL
mutationally	NULL
inactivated	NULL
Egr	NULL
sequence	NULL
)	NULL
and	NULL
pCMV-B-galactosidase	NULL
by	NULL
the	NULL
same	NULL
procedure	NULL
described	NULL
above	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
minimum	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

mRNA	NULL
in	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Abundant	NULL
tissue	NULL
factor	NULL
antigen	NULL
was	NULL
present	NULL
in	NULL
lungs	NULL
of	NULL
wild-type	NULL
mice	NULL
subjected	NULL
to	NULL
hypoxia	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
versus	NULL
wild-type	NULL
normoxic	NULL
controls	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Immunohistologic	NULL
studies	NULL
were	NULL
performed	NULL
on	NULL
animals	NULL
to	NULL
detect	NULL
tissue	NULL
factor	NULL
or	NULL
fibrin	NULL
antigen	NULL
(	NULL
see	NULL
below	NULL
)	NULL
by	NULL
using	NULL
Egr-1	NULL
null	NULL
mice	NULL
and	NULL
nontransgenic	NULL
littermates	NULL
.	NULL

For	NULL
each	NULL
animal	NULL
,	NULL
sections	NULL
from	NULL
every	NULL
lobe	NULL
of	NULL
one	NULL
lung	NULL
were	NULL
analyzed	NULL
;	NULL
sections	NULL
in	NULL
which	NULL
there	NULL
were	NULL
pulmonary	NULL
vessels	NULL
of	NULL
comparable	NULL
size	NULL
were	NULL
compared	NULL
,	NULL
and	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

Tissue	NULL
factor	NULL
antigen	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
D	NULL
and	NULL
F	NULL
)	NULL
was	NULL
colocalized	NULL
with	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
Fig	NULL
.	NULL

4€E	NULL
;	NULL
identified	NULL
using	NULL
the	NULL
F4/80	NULL
antibody	NULL
)	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4G	NULL
;	NULL
identified	NULL
using	NULL
antibody	NULL
to	NULL
smooth	NULL
muscle	NULL
-actin	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
tissue	NULL
factor	NULL
was	NULL
virtually	NULL
undetectable	NULL
in	NULL
lungs	NULL
from	NULL
hypoxic	NULL
and	NULL
normoxic	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
H	NULL
and	NULL
J	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
a	NULL
central	NULL
role	NULL
for	NULL
hypoxia-induced	NULL
tissue	NULL
factor	NULL
expression	NULL
in	NULL
fibrin	NULL
formation	NULL
in	NULL
the	NULL
vasculature	NULL
(	NULL
6	NULL
)	NULL
,	NULL
immunostaining	NULL
of	NULL
hypoxic	NULL
lung	NULL
with	NULL
antibody	NULL
to	NULL
y-y	NULL
chain	NULL
dimers	NULL
(	NULL
15	NULL
)	NULL
showed	NULL
intravascular	NULL
fibrin	NULL
in	NULL
samples	NULL
from	NULL
wild-type	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
,	NULL
whereas	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
fibrin	NULL
in	NULL
samples	NULL
from	NULL
normoxic	NULL
wild-type	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
fibrin	NULL
epitopes	NULL
were	NULL
observed	NULL
in	NULL
either	NULL
hypoxic	NULL
or	NULL
normoxic	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
and	NULL
D	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

To	NULL
more	NULL
quantitatively	NULL
assess	NULL
fibrin	NULL
deposition	NULL
in	NULL
lung	NULL
,	NULL
immunoblotting	NULL
with	NULL
antibody	NULL
to	NULL
y-y	NULL
chain	NULL
crosslinks	NULL
was	NULL
performed	NULL
on	NULL
lung	NULL
tissue	NULL
extracts	NULL
(	NULL
6	NULL
)	NULL
:	NULL
a	NULL
strong	NULL
immunoreactive	NULL
band	NULL
was	NULL
detected	NULL
in	NULL
samples	NULL
from	NULL
wild-type	NULL
hypoxic	NULL
mice	NULL
,	NULL
but	NULL
only	NULL
a	NULL
faint	NULL
band	NULL
was	NULL
seen	NULL
in	NULL
samples	NULL
from	NULL
normoxic	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

SE	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
very	NULL
weak	NULL
band	NULL
corresponding	NULL
to	NULL
fibrin	NULL
necoepitope	NULL
was	NULL
observed	NULL
in	NULL
either	NULL
normoxic	NULL
or	NULL
hypoxic	NULL
samples	NULL
from	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

SE	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

8302	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
'	NULL
w	NULL
-TF	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Hypoxia-mediated	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
expression	NULL
in	NULL
murine	NULL
lung	NULL
:	NULL
Egr-1	NULL
null	NULL
mice	NULL
show	NULL
reduced	NULL
tissue	NULL
factor	NULL
mRNA	NULL
(	NULL
4	NULL
)	NULL
and	NULL
antigen	NULL
(	NULL
BF	NULL
)	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Mice	NULL
(	NULL
wild-type	NULL
,	NULL
+/+	NULL
,	NULL
or	NULL
homozygous	NULL
null	NULL
mice	NULL
,	NULL
-/-	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
normoxia	NULL
(	NULL
N	NULL
)	NULL
or	NULL
hypoxia	NULL
(	NULL
H	NULL
;	NULL
6	NULL
%	NULL
oxygen	NULL
)	NULL
,	NULL
lungs	NULL
were	NULL
rapidly	NULL
harvested	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
,	NULL
and	NULL
Northern	NULL
analysis	NULL
(	NULL
30	NULL
pg/lane	NULL
of	NULL
total	NULL
RNA	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
32P	NULL
-labeled	NULL
cDNA	NULL
for	NULL
mouse	NULL
tissue	NULL
factor	NULL
(	NULL
Upper	NULL
)	NULL
or	NULL
B-actin	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

(	NULL
B-I	NULL
)	NULL
Immunohistochemical	NULL
analysis	NULL
for	NULL
tissue	NULL
factor	NULL
antigen	NULL
was	NULL
performed	NULL
on	NULL
lung	NULL
tissue	NULL
from	NULL
mice	NULL
exposed	NULL
to	NULL
normoxia	NULL
or	NULL
hypoxia	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Hypoxic	NULL
and	NULL
normoxic	NULL
wild-type	NULL
mouse	NULL
lung	NULL
,	NULL
respectively	NULL
,	NULL
stained	NULL
with	NULL
antitissue	NULL
factor	NULL
IgG	NULL
.	NULL

(	NULL
D	NULL
and	NULL
£	NULL
)	NULL
Higher-power	NULL
micro-graph	NULL
of	NULL
hypoxic	NULL
wild-type	NULL
mouse	NULL
lung	NULL
stained	NULL
with	NULL
anti-tissue	NULL
factor	NULL
IgG	NULL
(	NULL
D	NULL
)	NULL
with	NULL
an	NULL
adjacent	NULL
section	NULL
stained	NULL
with	NULL
antibody	NULL
to	NULL
F4/80	NULL
to	NULL
detect	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
E	NULL
)	NULL
.	NULL

(	NULL
F	NULL
and	NULL
G	NULL
)	NULL
Higher-power	NULL
micro-graph	NULL
of	NULL
hypoxic	NULL
wild-type	NULL
mouse	NULL
lung	NULL
stained	NULL
with	NULL
anti-tissue	NULL
factor	NULL
IgG	NULL
(	NULL
F	NULL
)	NULL
with	NULL
an	NULL
adjacent	NULL
section	NULL
stained	NULL
with	NULL
antibody	NULL
to	NULL
smooth	NULL
muscle	NULL
«	NULL
-actin	NULL
(	NULL
G	NULL
)	NULL
.	NULL

(	NULL
H	NULL
and	NULL
I	NULL
)	NULL
Hypoxic	NULL
and	NULL
normoxic	NULL
egr-1	NULL
-/-mouse	NULL
stained	NULL
with	NULL
anti-tissue	NULL
factor	NULL
IgG	NULL
.	NULL

[	NULL
X200	NULL
(	NULL
B	NULL
and	NULL
C	NULL
,	NULL
F-7	NULL
)	NULL
and	NULL
X600	NULL
(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
.	NULL
]	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

DISCUSSION	NULL
Mononuclear	NULL
phagocytes	NULL
subjected	NULL
to	NULL
hypoxia	NULL
/hypoxemia	NULL
display	NULL
enhanced	NULL
tissue	NULL
factor	NULL
expression	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
a	NULL
novel	NULL
scenario	NULL
for	NULL
hypoxia-induced	NULL
thrombosis	NULL
associated	NULL
with	NULL
diminished	NULL
blood	NULL
flow	NULL
or	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
E	NULL
1	NULL
2	NULL
3	NULL
4	NULL
woe	NULL
@	NULL
#	NULL
sot	NULL
e-	NULL
»	NULL
--	NULL
Fibrin	NULL
N	NULL
H	NULL
N	NULL
H	NULL
--	NULL
0	NULL
<	NULL
-+/+	NULL
-	NULL
-/-	NULL
-	NULL
-=-	NULL
Genotype	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Hypoxia-mediated	NULL
induction	NULL
of	NULL
fibrin	NULL
deposition	NULL
in	NULL
murine	NULL
lung	NULL
:	NULL
egr-1	NULL
null	NULL
mice	NULL
show	NULL
no	NULL
increase	NULL
in	NULL
fibrin	NULL
deposition	NULL
.	NULL

Wild-type	NULL
or	NULL
homozygous	NULL
Egr-1	NULL
null	NULL
mice	NULL
were	NULL
subjected	NULL
to	NULL
hypoxia	NULL
as	NULL
above	NULL
.	NULL

(	NULL
4-D	NULL
)	NULL
Immunostaining	NULL
was	NULL
performed	NULL
with	NULL
antibody	NULL
to	NULL
fibrin	NULL
y-y	NULL
chain	NULL
crosslinks	NULL
(	NULL
15	NULL
)	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Hypoxic	NULL
wild-type	NULL
murine	NULL
lung	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Normoxic	NULL
wild-type	NULL
murine	NULL
lung	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Hypoxic	NULL
Egr-1	NULL
-/-	NULL
murine	NULL
lung	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Normoxic	NULL
Egr-1	NULL
-/-	NULL
murine	NULL
lung	NULL
.	NULL

(	NULL
xX200	NULL
.	NULL
)	NULL

(	NULL
E	NULL
)	NULL
Immunoblotting	NULL
(	NULL
5	NULL
)	NULL
using	NULL
the	NULL
antibody	NULL
to	NULL
y-y	NULL
chain	NULL
crosslinks	NULL
(	NULL
15	NULL
)	NULL
was	NULL
performed	NULL
on	NULL
plasmin-treated	NULL
extracts	NULL
of	NULL
murine	NULL
lung	NULL
harvested	NULL
from	NULL
normoxic	NULL
(	NULL
N	NULL
)	NULL
/hypoxic	NULL
(	NULL
H	NULL
)	NULL
wild-type	NULL
or	NULL
Egr-1	NULL
-/-	NULL
mice	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
a	NULL
minimum	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

frank	NULL
stasis	NULL
.	NULL

Blood	NULL
monocytes	NULL
become	NULL
arrested	NULL
(	NULL
6	NULL
)	NULL
and	NULL
activated	NULL
at	NULL
sites	NULL
of	NULL
hypoxemic	NULL
vascular	NULL
injury	NULL
potentially	NULL
because	NULL
of	NULL
signals	NULL
emitted	NULL
by	NULL
hypoxic	NULL
endothelium	NULL
.	NULL

Perturbation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
the	NULL
oxygen-depleted	NULL
environment	NULL
causes	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
,	NULL
allowing	NULL
coagulation	NULL
to	NULL
be	NULL
initiated	NULL
,	NULL
and	NULL
activated	NULL
products	NULL
of	NULL
the	NULL
procoagulant	NULL
pathway	NULL
accumulate	NULL
in	NULL
static	NULL
portions	NULL
of	NULL
the	NULL
vascular	NULL
tree	NULL
.	NULL

This	NULL
biology	NULL
of	NULL
thrombosis	NULL
is	NULL
especially	NULL
relevant	NULL
to	NULL
venous	NULL
valve	NULL
pockets	NULL
,	NULL
which	NULL
are	NULL
frequently	NULL
subject	NULL
to	NULL
stasis	NULL
and	NULL
are	NULL
a	NULL
well	NULL
known	NULL
nidus	NULL
for	NULL
clot	NULL
formation	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

A	NULL
contribution	NULL
of	NULL
endothelium	NULL
may	NULL
be	NULL
at	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
chemotactic	NULL
activity	NULL
;	NULL
monocyte	NULL
chemotactic	NULL
protein-1	NULL
(	NULL
JE/MCP-1	NULL
)	NULL
is	NULL
expressed	NULL
by	NULL
hypoxic	NULL
endothelial	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
the	NULL
biology	NULL
of	NULL
hypoxia-mediated	NULL
thrombosis	NULL
assigns	NULL
monocytes	NULL
a	NULL
central	NULL
role	NULL
to	NULL
effect	NULL
a	NULL
primordial	NULL
response	NULL
causing	NULL
isolation	NULL
of	NULL
an	NULL
ischemic	NULL
area	NULL
from	NULL
the	NULL
circulation	NULL
by	NULL
a	NULL
protective	NULL
fibrin	NULL
clot	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
providing	NULL
insights	NULL
into	NULL
a	NULL
key	NULL
mechanism	NULL
underlying	NULL
hypoxia-induced	NULL
thrombosis	NULL
,	NULL
our	NULL
studies	NULL
have	NULL
demonstrated	NULL
a	NULL
pathophysiologically	NULL
relevant	NULL
model	NULL
of	NULL
hypoxia-associated	NULL
gene	NULL
regulation	NULL
independent	NULL
of	NULL
HIF-1	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Egr-1	NULL
in	NULL
physiologic	NULL
and	NULL
pathophysiologic	NULL
(	NULL
22	NULL
)	NULL
processes	NULL
has	NULL
been	NULL
clarified	NULL
by	NULL
observations	NULL
in	NULL
Egr-1	NULL
null	NULL
mice	NULL
(	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Whereas	NULL
Egr-1	NULL
was	NULL
postulated	NULL
to	NULL
be	NULL
an	NULL
essential	NULL
factor	NULL
in	NULL
macrophage	NULL
differentiation	NULL
(	NULL
23	NULL
)	NULL
and	NULL
multiple	NULL
other	NULL
basic	NULL
cellular	NULL
homeostatic	NULL
events	NULL
(	NULL
22	NULL
)	NULL
,	NULL
based	NULL
on	NULL
in	NULL
vitro	NULL
studies	NULL
,	NULL
analysis	NULL
of	NULL
Egr-1	NULL
null	NULL
mice	NULL
has	NULL
not	NULL
borne	NULL
out	NULL
many	NULL
of	NULL
these	NULL
predictions	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
phenotype	NULL
of	NULL
Egr-1	NULL
knockout	NULL
mice	NULL
becomes	NULL
evident	NULL
only	NULL
after	NULL
environmental	NULL
stress	NULL
:	NULL
female	NULL
homozygote	NULL
knockout	NULL
mice	NULL
are	NULL
sterile	NULL
because	NULL
of	NULL
luteinizing	NULL
hormone	NULL
(	NULL
LH	NULL
)	NULL
-	NULL
$	NULL
deficiency	NULL
,	NULL
an	NULL
effect	NULL
mediated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
LH-	NULL
transcription	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
Egr-1	NULL
is	NULL
necessary	NULL
for	NULL
tissue	NULL
factor	NULL
induction	NULL
in	NULL
the	NULL
setting	NULL
Medical	NULL
Sciences	NULL
:	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

of	NULL
environmental	NULL
oxygen	NULL
deprivation	NULL
.	NULL

The	NULL
potential	NULL
significance	NULL
of	NULL
Egr-1	NULL
activation	NULL
in	NULL
hypoxia	NULL
concerns	NULL
the	NULL
range	NULL
of	NULL
potential	NULL
target	NULL
genes	NULL
and	NULL
cellular	NULL
functions	NULL
thereby	NULL
stimulated	NULL
by	NULL
these	NULL
gene	NULL
products	NULL
.	NULL

Of	NULL
these	NULL
,	NULL
we	NULL
previously	NULL
have	NULL
observed	NULL
enhanced	NULL
expression	NULL
of	NULL
intercellular	NULL
adhesion	NULL
mol-ecule-1	NULL
in	NULL
hypoxemic	NULL
vasculature	NULL
(	NULL
24	NULL
)	NULL
,	NULL
where	NULL
it	NULL
could	NULL
have	NULL
an	NULL
important	NULL
role	NULL
in	NULL
arresting	NULL
leukocytes	NULL
in	NULL
ischemic	NULL
tissues	NULL
.	NULL

These	NULL
considerations	NULL
suggest	NULL
that	NULL
there	NULL
may	NULL
be	NULL
important	NULL
contrasts	NULL
between	NULL
hypoxia-induced	NULL
adaptive	NULL
responses	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
HIF-1	NULL
(	NULL
17	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
and	NULL
those	NULL
that	NULL
we	NULL
think	NULL
to	NULL
be	NULL
under	NULL
control	NULL
of	NULL
Egr-1	NULL
.	NULL

Many	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
HIF-1	NULL
regulates	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
metabolic	NULL
adjustment	NULL
to	NULL
oxygen	NULL
deprivation	NULL
[	NULL
glycolytic	NULL
enzymes	NULL
(	NULL
27-30	NULL
)	NULL
and	NULL
the	NULL
noninsulin-dependent	NULL
glucose	NULL
transporter	NULL
,	NULL
GLUT	NULL
(	NULL
31	NULL
)	NULL
]	NULL
,	NULL
angiogenesis	NULL
(	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
;	NULL
ref	NULL
.	NULL

32	NULL
)	NULL
,	NULL
and	NULL
vasomotor	NULL
control	NULL
(	NULL
nitric-oxide	NULL
synthase	NULL
and	NULL
heme	NULL
oxygenase	NULL
;	NULL
refs	NULL
.	NULL

33	NULL
and	NULL
34	NULL
)	NULL
.	NULL

Egr-1-mediated	NULL
gene	NULL
expression	NULL
appears	NULL
to	NULL
orchestrate	NULL
thromobogenesis	NULL
and	NULL
,	NULL
potentially	NULL
,	NULL
cell-cell	NULL
interactions	NULL
and	NULL
inflammatory	NULL
mechanisms	NULL
(	NULL
18	NULL
,	NULL
35-37	NULL
)	NULL
,	NULL
suggesting	NULL
activation	NULL
of	NULL
a	NULL
distinct	NULL
type	NULL
of	NULL
host	NULL
response	NULL
mechanisms	NULL
in	NULL
the	NULL
hypoxemic	NULL
milieu	NULL
.	NULL

The	NULL
range	NULL
of	NULL
Egr-1	NULL
target	NULL
genes	NULL
activated	NULL
by	NULL
hypoxia	NULL
and	NULL
their	NULL
consequences	NULL
for	NULL
the	NULL
host	NULL
response	NULL
to	NULL
oxygen	NULL
deprivation	NULL
provide	NULL
a	NULL
new	NULL
approach	NULL
to	NULL
the	NULL
biology	NULL
of	NULL
thrombosis	NULL
and	NULL
effector	NULL
mechanisms	NULL
triggered	NULL
in	NULL
ischemia	NULL
.	NULL

Dr.	NULL
Gabriel	NULL
Godman	NULL
provided	NULL
valuable	NULL
suggestions	NULL
during	NULL
the	NULL
course	NULL
of	NULL
this	NULL
work	NULL
and	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
(	NULL
HL35246	NULL
to	NULL
W.K	NULL
.	NULL

;	NULL
HL42507	NULL
,	NULL
HL55397	NULL
,	NULL
and	NULL
HD13063C	NULL
to	NULL
D.S	NULL
.	NULL
)	NULL

and	NULL
the	NULL
Surgical	NULL
Research	NULL
Fund	NULL
.	NULL

1	NULL
.	NULL

Geerts	NULL
,	NULL
W.	NULL
,	NULL
Code	NULL
,	NULL
K.	NULL
,	NULL
Jay	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
E.	NULL
&	NULL
Szalai	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

331	NULL
,	NULL
1601-1606	NULL
.	NULL

2	NULL
.	NULL

Anderson	NULL
,	NULL
F.	NULL
,	NULL
Wheeler	NULL
,	NULL
H.	NULL
,	NULL
Goldberg	NULL
,	NULL
R.	NULL
,	NULL
Hosmer	NULL
,	NULL
D.	NULL
,	NULL
Pat	NULL
wardhan	NULL
,	NULL
N.	NULL
,	NULL
Jovanovic	NULL
,	NULL
B.	NULL
,	NULL
Forcier	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Dalen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Arch	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

151	NULL
,	NULL
933-938	NULL
.	NULL

Malone	NULL
,	NULL
P.	NULL
&	NULL
Morris	NULL
,	NULL
C.	NULL
(	NULL
1978	NULL
)	NULL
J.	NULL
Pathol	NULL
.	NULL

125	NULL
,	NULL
119-129	NULL
.	NULL

Hamer	NULL
,	NULL
J.	NULL
,	NULL
Malone	NULL
,	NULL
P.	NULL
&	NULL
Silver	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Surg	NULL
.	NULL

68	NULL
,	NULL
166-170	NULL
.	NULL

Malone	NULL
,	NULL
P.	NULL
(	NULL
1977	NULL
)	NULL
Med	NULL
.	NULL

Hypotheses	NULL
5	NULL
,	NULL
189-201	NULL
.	NULL

Lawson	NULL
,	NULL
C.	NULL
,	NULL
Laio	NULL
,	NULL
H.	NULL
,	NULL
Yan	NULL
,	NULL
S.-D.	NULL
,	NULL
Yan	NULL
,	NULL
S.-F.	NULL
,	NULL
Sobel	NULL
,	NULL
J.	NULL
,	NULL
Kisiel	NULL
,	NULL
W.	NULL
,	NULL
Stern	NULL
,	NULL
D.	NULL
&	NULL
Pinsky	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99	NULL
,	NULL
1729-1738	NULL
.	NULL

Yan	NULL
,	NULL
S.-F.	NULL
,	NULL
Tritto	NULL
,	NULL
I.	NULL
,	NULL
Pinsky	NULL
,	NULL
D.	NULL
,	NULL
Liao	NULL
,	NULL
H.	NULL
,	NULL
Huang	NULL
,	NULL
J.	NULL
,	NULL
Fuller	NULL
,	NULL
G.	NULL
,	NULL
Brett	NULL
,	NULL
J.	NULL
,	NULL
May	NULL
,	NULL
L.	NULL
&	NULL
Stern	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
11463-11471	NULL
.	NULL

8	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

9	NULL
.	NULL

Cui	NULL
,	NULL
M.-Z	NULL
.	NULL

,	NULL
Parry	NULL
,	NULL
G.	NULL
,	NULL
Oceth	NULL
,	NULL
P.	NULL
,	NULL
Larson	NULL
,	NULL
H.	NULL
,	NULL
Smith	NULL
,	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
R.-P.	NULL
,	NULL
Adamson	NULL
,	NULL
E.	NULL
&	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
2731-2739	NULL
.	NULL

10	NULL
.	NULL

Semenza	NULL
,	NULL
G.	NULL
&	NULL
Wang	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
5447-5454	NULL
.	NULL

11	NULL
.	NULL

-	NULL
Sambrook	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

a	NULL
i	NULL
p	NULL
po	NULL
~	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
(	NULL
1998	NULL
)	NULL
8303	NULL
Lee	NULL
,	NULL
S.	NULL
,	NULL
Sadovsky	NULL
,	NULL
Y.	NULL
,	NULL
Swirnoff	NULL
,	NULL
A.	NULL
,	NULL
Polish	NULL
,	NULL
J.	NULL
,	NULL
Goda	NULL
,	NULL
P.	NULL
,	NULL
Gavrilina	NULL
,	NULL
G.	NULL
&	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Science	NULL
273	NULL
,	NULL
1219-1221	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
,	NULL
Wang	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
4566-4572	NULL
.	NULL

Yan	NULL
,	NULL
S.-F.	NULL
,	NULL
Mendelsohn	NULL
,	NULL
M.	NULL
,	NULL
Zou	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
Gao	NULL
,	NULL
Y.	NULL
,	NULL
Naka	NULL
,	NULL
Y.	NULL
,	NULL
Yan	NULL
,	NULL
S.-D.	NULL
,	NULL
Pinsky	NULL
,	NULL
D.	NULL
&	NULL
Stern	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
4287-4294	NULL
.	NULL

Lahiri	NULL
,	NULL
B.	NULL
,	NULL
Koehn	NULL
,	NULL
J.	NULL
,	NULL
Canfield	NULL
,	NULL
R.	NULL
,	NULL
Birken	NULL
,	NULL
S.	NULL
&	NULL
Lewis	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Thromb	NULL
.	NULL

Res	NULL
.	NULL

23	NULL
,	NULL
103-112	NULL
.	NULL

O'Rourke	NULL
,	NULL
J.	NULL
,	NULL
Pugh	NULL
,	NULL
C.	NULL
,	NULL
Bartlett	NULL
,	NULL
S.	NULL
&	NULL
Ratcliffe	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

241	NULL
,	NULL
403-410	NULL
.	NULL

Guillemin	NULL
,	NULL
K.	NULL
&	NULL
Krasnow	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
89	NULL
,	NULL
9-12	NULL
.	NULL

Khachigian	NULL
,	NULL
L.	NULL
,	NULL
Lindner	NULL
,	NULL
V.	NULL
,	NULL
Williams	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Collins	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
271	NULL
,	NULL
1427-1431	NULL
.	NULL

Khachigian	NULL
,	NULL
L.	NULL
,	NULL
Williams	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Collins	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
27679-27686	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
,	NULL
Tourtellotte	NULL
,	NULL
L.	NULL
,	NULL
Wesselschmidt	NULL
,	NULL
R.	NULL
&	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
9971-9977	NULL
.	NULL

Karakurum	NULL
,	NULL
M.	NULL
,	NULL
Shreeniwas	NULL
,	NULL
R.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Sunouchi	NULL
,	NULL
J.	NULL
,	NULL
Hamil-ton	NULL
,	NULL
T.	NULL
,	NULL
Anderson	NULL
,	NULL
M.	NULL
,	NULL
Kuwabara	NULL
,	NULL
K.	NULL
,	NULL
Rot	NULL
,	NULL
A.	NULL
,	NULL
Nowygrod	NULL
,	NULL
R.	NULL
&	NULL
Stern	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

93	NULL
,	NULL
1564-1570	NULL
.	NULL

Gashler	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Sukhatme	NULL
,	NULL
V.	NULL
(	NULL
1995	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

50	NULL
,	NULL
191-224	NULL
.	NULL

Nguyen	NULL
,	NULL
H.	NULL
,	NULL
Hoffman-Liecbermann	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Liebermann	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
197-209	NULL
.	NULL

Shreeniwas	NULL
R.	NULL
,	NULL
Koga	NULL
,	NULL
S.	NULL
,	NULL
Pinsky	NULL
,	NULL
D.	NULL
,	NULL
Kaiser	NULL
,	NULL
E.	NULL
,	NULL
Brett	NULL
,	NULL
J.	NULL
,	NULL
Wolitzky	NULL
,	NULL
B.	NULL
,	NULL
Norton	NULL
,	NULL
C.	NULL
,	NULL
Plocinski	NULL
,	NULL
J.	NULL
,	NULL
Benjamin	NULL
,	NULL
W.	NULL
,	NULL
Burns	NULL
,	NULL
D.	NULL
,	NULL
Goldstein	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Stern	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
2333-2339	NULL
.	NULL

Semenza	NULL
,	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Trends	NULL
Cardiovasc	NULL
.	NULL

Med	NULL
.	NULL

6	NULL
,	NULL
151-158	NULL
.	NULL

Ratcliffe	NULL
,	NULL
P.	NULL
,	NULL
Ebert	NULL
,	NULL
B.	NULL
,	NULL
Firth	NULL
,	NULL
J.	NULL
,	NULL
Gleadle	NULL
,	NULL
J.	NULL
,	NULL
Maxwell	NULL
,	NULL
P.	NULL
,	NULL
Nagao	NULL
,	NULL
M.	NULL
,	NULL
O'Rourke	NULL
,	NULL
J.	NULL
,	NULL
Pugh	NULL
,	NULL
C.	NULL
&	NULL
Wood	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Kidney	NULL
Inil	NULL
.	NULL

51	NULL
,	NULL
514-526	NULL
.	NULL

Semenza	NULL
,	NULL
G.	NULL
,	NULL
Roth	NULL
,	NULL
P.	NULL
,	NULL
Fang	NULL
,	NULL
H.-M.	NULL
&	NULL
Wang	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
23757-23763	NULL
.	NULL

Firth	NULL
,	NULL
J.	NULL
,	NULL
Ebert	NULL
,	NULL
B.	NULL
,	NULL
Pugh	NULL
,	NULL
C.	NULL
&	NULL
Ratcliffe	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
6496-6500	NULL
.	NULL

Firth	NULL
,	NULL
J.	NULL
,	NULL
Ebert	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Ratcliffe	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
21021-21027	NULL
.	NULL

Ebert	NULL
,	NULL
B.	NULL
,	NULL
Gleadle	NULL
,	NULL
J.	NULL
,	NULL
O'Rourke	NULL
,	NULL
J.	NULL
,	NULL
Bartlett	NULL
,	NULL
S.	NULL
,	NULL
Poulton	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Ratcliffe	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

313	NULL
,	NULL
809-814	NULL
.	NULL

Ebert	NULL
,	NULL
B.	NULL
,	NULL
Firth	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Ratcliffe	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
29083-29089	NULL
.	NULL

Shweiki	NULL
,	NULL
D.	NULL
,	NULL
Itin	NULL
,	NULL
A.	NULL
,	NULL
Soffer	NULL
,	NULL
D.	NULL
&	NULL
Keshet	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
359	NULL
,	NULL
843-845	NULL
.	NULL

McQuillan	NULL
,	NULL
L.	NULL
,	NULL
Leung	NULL
,	NULL
G.	NULL
,	NULL
Marsden	NULL
,	NULL
P.	NULL
,	NULL
Kostyk	NULL
,	NULL
S.	NULL
&	NULL
Kourembanas	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

267	NULL
,	NULL
H1921-H1927	NULL
.	NULL

Morita	NULL
,	NULL
T.	NULL
,	NULL
Perrella	NULL
,	NULL
M.	NULL
,	NULL
Lee	NULL
,	NULL
M.-E.	NULL
&	NULL
Kourembanas	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
1475-1479	NULL
.	NULL

Maltzman	NULL
,	NULL
J.	NULL
,	NULL
Carman	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Monroe	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
1747-1759	NULL
.	NULL

Skerka	NULL
,	NULL
C.	NULL
,	NULL
Decker	NULL
,	NULL
E.	NULL
&	NULL
Zipfel	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
22500-22506	NULL
.	NULL

Kramer	NULL
,	NULL
B.	NULL
,	NULL
Meichle	NULL
,	NULL
A.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Charnay	NULL
,	NULL
P.	NULL
&	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1219	NULL
,	NULL
413-421	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
Muller	NULL
,	NULL
S.	NULL
,	NULL
Beato	NULL
,	NULL
M.	NULL
&	NULL
Suske	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
3843-3851	NULL
.	NULL

